Literature DB >> 29601068

Possible refinement of the standard treatment of esophageal cancer.

Cheng-Che Tu1, Po-Kuei Hsu2.   

Abstract

Entities:  

Year:  2018        PMID: 29601068      PMCID: PMC5863187          DOI: 10.21037/jtd.2017.12.74

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  10 in total

1.  Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma.

Authors:  Jin Lv; Xiu Feng Cao; Bin Zhu; Lv Ji; Lei Tao; Dong Dong Wang
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

2.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

3.  Trimodality therapy for esophageal squamous cell carcinoma: Is it really a medical palindrome?

Authors:  Usman Ahmad; Sudish C Murthy; Siva Raja
Journal:  J Thorac Cardiovasc Surg       Date:  2017-04-03       Impact factor: 5.209

4.  Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.

Authors:  Po-Kuei Hsu; Chien-Sheng Huang; Bing-Yen Wang; Yu-Chung Wu; Wen-Hu Hsu
Journal:  Ann Thorac Surg       Date:  2014-03-06       Impact factor: 4.330

5.  Role of the modern radiotherapy in the postoperative setting for esophageal cancer.

Authors:  Gian-Carlo Mattiucci; Francesco Cellini
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Esophageal and esophagogastric junction cancers, version 1.2015.

Authors:  Jaffer A Ajani; Thomas A D'Amico; Khaldoun Almhanna; David J Bentrem; Stephen Besh; Joseph Chao; Prajnan Das; Crystal Denlinger; Paul Fanta; Charles S Fuchs; Hans Gerdes; Robert E Glasgow; James A Hayman; Steven Hochwald; Wayne L Hofstetter; David H Ilson; Dawn Jaroszewski; Kory Jasperson; Rajesh N Keswani; Lawrence R Kleinberg; W Michael Korn; Stephen Leong; A Craig Lockhart; Mary F Mulcahy; Mark B Orringer; James A Posey; George A Poultsides; Aaron R Sasson; Walter J Scott; Vivian E Strong; Thomas K Varghese; Mary Kay Washington; Christopher G Willett; Cameron D Wright; Debra Zelman; Nicole McMillian; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2015-02       Impact factor: 11.908

7.  Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Po-Kuei Hsu; Hui-Shan Chen; Chia-Chuan Liu; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Shiao-Chi Wu
Journal:  J Thorac Cardiovasc Surg       Date:  2017-03-21       Impact factor: 5.209

8.  Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.

Authors:  M Tachibana; H Yoshimura; S Kinugasa; M Shibakita; D K Dhar; S Ueda; T Fujii; N Nagasue
Journal:  Eur J Surg Oncol       Date:  2003-09       Impact factor: 4.424

9.  A Propensity-matched Analysis Comparing Survival After Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma.

Authors:  Jwu-Yun Hwang; Hui-Shan Chen; Po-Kuei Hsu; Yin-Kai Chao; Bing-Yen Wang; Chien-Sheng Huang; Chia-Chuan Liu; Shiao-Chi Wu
Journal:  Ann Surg       Date:  2016-07       Impact factor: 12.969

10.  Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.

Authors:  Cheng-Che Tu; Po-Kuei Hsu; Ling-I Chien; Wan-Chen Liu; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Yu-Chung Wu
Journal:  BMC Cancer       Date:  2017-01-19       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.